CASP1 and peripheral arterial disease: In the setting of PAD, as shown in a study by Cai et al., diabetic PAD patients demonstrated markedly increased expression of NLRP3, ASC, and caspase-1 in affected arterial tissue compared to diabetic patients without PAD [64].